(Q34699629)

4 August 2017

Prostaglandins, aspirin-like drugs and analgesia (English)

1 reference

4 August 2017

Prostaglandins, Aspirin-like Drugs and Analgesia (English)

1 reference

https://api.crossref.org/works/10.1038/NEWBIO240200A0

15 February 2023

1 reference

S. H. Ferreira

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4629913

15 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4629913

15 February 2023

publication date

1 December 1972

1 reference

4 August 2017

13 December 1972

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4629913

full work available at URL

15 February 2023

http://www.nature.com/articles/newbio240200a0.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/NEWBIO240200A0

http://www.nature.com/articles/newbio240200a0

15 February 2023

1 reference

https://api.crossref.org/works/10.1038/NEWBIO240200A0

15 February 2023

1 reference

4 August 2017

240

1 reference

4 August 2017

200-203

1 reference

4 August 2017

102

1 reference

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

4 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Aspirin selectively inhibits prostaglandin production in human platelets

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Indomethacin and aspirin abolish prostaglandin release from the spleen

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Cutaneous reactions to intradermal prostaglandins

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Action of Prostaglandin E1 on Tissues which respond to Bradykinin

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Prostaglandin-oxytocin enhancement and potentiation and their clinical applications.

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Action of prostaglandin in the pregnant woman

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Nociceptive Response to Prostaglandins and Analgesic Actions of Aspirin and Morphine

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

The release of prostaglandins and rabbit aorta contracting substance (RCS) from rabbit spleen and its antagonism by anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Experimental evidence on the nature of cutaneous hyperalgesia

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Prostaglandin-norepinephrine interactions in brain: microelectrophoretic and histochemical correlates.

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Prostaglandins and neuronal activity in spinal and cuneate nucleus

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Lipid peroxide formation in experimental inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FNEWBIO240200A0

7 January 2021

Industrial and engineering chemistry

14

19

980

CD Wagner

1947

1 reference

https://api.crossref.org/works/10.1038/NEWBIO240200A0

15 February 2023

Identifiers

0 references

1 reference